Join
Live feed
·
INSIDERFilingvia Quantisnow
CNS Pharmaceuticals Inc. logo

Downs Christopher bought $20,000 worth of shares (66,666 units at $0.30), increasing direct ownership by 181% to 103,438 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CNSP· CNS Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNSP (CNS Pharmaceuticals Inc.) and more on Quantisnow.